• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者非勺型血压模式频率增加:24小时动态血压监测的见解

Increased Frequency of the Non-Dipper Blood Pressure Pattern in Patients with Systemic Sclerosis: Insights from 24-Hour Ambulatory Monitoring.

作者信息

Zengin Oğuzhan, Soytürk Gülşah, Göre Burak, Yürümez Mustafa, Kurtipek Ali Can, Kalkan Emra Asfuroğlu, Konak Hatice Ecem, Erten Şükran, Ateş Ihsan

机构信息

Department of Internal Medicine, University of Health Sciences, Ankara Bilkent City Hospital, 06800 Ankara, Turkey.

Department of Rheumatology, Ankara Bilkent City Hospital, 06800 Ankara, Turkey.

出版信息

J Pers Med. 2025 Jun 15;15(6):253. doi: 10.3390/jpm15060253.

DOI:10.3390/jpm15060253
PMID:40559115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12194108/
Abstract

In systemic sclerosis (SSc), endothelial dysfunction, inflammation, and reduced nitric oxide levels may disrupt circadian blood pressure (BP) regulation. There are studies showing that inflammatory and certain other cells in diseases like SSc exhibit diurnal rhythms. In our study, we examined the effect of SSc on BP. In particular, the frequency of the non-dipper pattern (lack of nighttime BP reduction) in SSc patients has not been adequately investigated. The aim of this study was to evaluate the 24 h BP profile in SSc patients and to compare the frequency of the non-dipper pattern with that of the non-scleroderma group. Additionally, the identification of disrupted circadian BP patterns in SSc patients aims to contribute to the development of personalized, time-sensitive BP monitoring strategies in the future and to support the applicability of personalized medicine in this context. A total of 31 SSc patients diagnosed according to the 2013 ACR/EULAR classification criteria and 30 age- and sex-matched individuals without SSc were included in this prospective study. BP changes between day and night were evaluated by measuring BP every 30 min with a 24 h ambulatory blood pressure monitoring (ABPM) device. The non-dipper pattern was defined as a decrease in BP of less than 10% during the night compared to the day. To better assess BP fluctuations during the night, nighttime measurements were divided into two time periods: first, 24:00-04:00, and then 04:00-08:00. Additionally, laboratory and clinical parameters and SSc subtypes were compared between the groups. The ABPM findings were compared between the groups with and without SSc. The non-dipper pattern was significantly more common in the SSc group at all time intervals. The non-dipper pattern was observed in 25.8% of the non-SSc group and 83.9% of SSc patients ( < 0.001). In the period between 24:00 and 04:00, the prevalence was 25.8% in the control group and 71.0% in SSc patients ( < 0.001), and between 04:00 and 08:00, it was 35.5% in the control group and 80.6% in SSc patients ( < 0.001). No significant difference was found in non-dipper patterns between individuals with diffuse and limited cutaneous forms of systemic sclerosis. The non-dipper BP pattern is significantly more common in patients with SSc, indicating the disruption of the circadian rhythm affecting BP. Analysis performed by dividing the night into specific time periods revealed that this deterioration continued throughout the night. The findings highlight the importance of circadian BP monitoring in SSc patients and may contribute to future risk stratification and treatment strategies. Circadian BP analysis in SSc may help to develop strategies that are personalized for these patients and tailored to their physiological rhythm.

摘要

在系统性硬化症(SSc)中,内皮功能障碍、炎症以及一氧化氮水平降低可能会扰乱昼夜血压(BP)调节。有研究表明,在诸如SSc等疾病中,炎症细胞和某些其他细胞呈现昼夜节律。在我们的研究中,我们检测了SSc对血压的影响。特别是,SSc患者中无勺型模式(夜间血压未降低)的频率尚未得到充分研究。本研究的目的是评估SSc患者的24小时血压概况,并将无勺型模式的频率与非硬皮病组进行比较。此外,识别SSc患者中昼夜血压模式的紊乱旨在为未来制定个性化的、对时间敏感的血压监测策略做出贡献,并支持个性化医疗在这种情况下的适用性。根据2013年美国风湿病学会(ACR)/欧洲抗风湿病联盟(EULAR)分类标准诊断的31例SSc患者和30例年龄及性别匹配的非SSc个体纳入了这项前瞻性研究。通过使用24小时动态血压监测(ABPM)设备每30分钟测量一次血压来评估昼夜血压变化。无勺型模式定义为夜间血压较白天降低少于10%。为了更好地评估夜间血压波动,夜间测量被分为两个时间段:首先是24:00 - 04:00,然后是04:00 - 08:00。此外,还比较了两组之间的实验室和临床参数以及SSc亚型。比较了有和没有SSc的两组之间的ABPM结果。在所有时间间隔内,无勺型模式在SSc组中显著更常见。非SSc组中25.8%观察到无勺型模式,而SSc患者中为83.9%(<0.001)。在24:00至04:00期间,对照组患病率为25.8%,SSc患者为71.0%(<0.001);在04:00至08:期间,对照组为35.5%,SSc患者为80.6%(<0.001)。弥漫性和局限性皮肤型系统性硬化症患者之间的无勺型模式无显著差异。SSc患者中无勺型血压模式显著更常见,表明影响血压的昼夜节律受到扰乱。将夜间分为特定时间段进行分析发现,这种恶化在整个夜间持续存在。这些发现突出了在SSc患者中进行昼夜血压监测的重要性,并可能有助于未来的风险分层和治疗策略。SSc中的昼夜血压分析可能有助于制定针对这些患者并根据其生理节律量身定制的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a25/12194108/428f18c9a523/jpm-15-00253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a25/12194108/3c00bac2b442/jpm-15-00253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a25/12194108/428f18c9a523/jpm-15-00253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a25/12194108/3c00bac2b442/jpm-15-00253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a25/12194108/428f18c9a523/jpm-15-00253-g002.jpg

相似文献

1
Increased Frequency of the Non-Dipper Blood Pressure Pattern in Patients with Systemic Sclerosis: Insights from 24-Hour Ambulatory Monitoring.系统性硬化症患者非勺型血压模式频率增加:24小时动态血压监测的见解
J Pers Med. 2025 Jun 15;15(6):253. doi: 10.3390/jpm15060253.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Stem cell transplantation for systemic sclerosis.系统性硬皮病的干细胞移植。
Cochrane Database Syst Rev. 2022 Jul 29;7(7):CD011819. doi: 10.1002/14651858.CD011819.pub2.
9
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
10
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.

本文引用的文献

1
Endothelin-1 as a Candidate Biomarker of Systemic Sclerosis: A GRADE-Assessed Systematic Review and Meta-Analysis With Meta-Regression.内皮素-1作为系统性硬化症的候选生物标志物:一项采用GRADE评估的系统评价和Meta回归的Meta分析
Biomark Insights. 2025 Feb 21;20:11772719251318555. doi: 10.1177/11772719251318555. eCollection 2025.
2
Cardiac Morpho-Functional Changes, Inflammation and Fibrosis in Systemic Sclerosis-A Pilot Study of a Tertiary Center Cohort.系统性硬化症中心脏形态功能变化、炎症及纤维化——一项三级中心队列的初步研究
Diagnostics (Basel). 2025 Feb 6;15(3):393. doi: 10.3390/diagnostics15030393.
3
Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis.
血管内皮生长因子作为系统性硬化症的潜在生物标志物:一项系统评价和荟萃分析。
Front Immunol. 2024 Nov 28;15:1442913. doi: 10.3389/fimmu.2024.1442913. eCollection 2024.
4
Methotrexate, blood pressure and arterial function in rheumatoid arthritis: study protocol.甲氨蝶呤、类风湿关节炎患者的血压和动脉功能:研究方案。
Future Cardiol. 2024;20(13):671-683. doi: 10.1080/14796678.2024.2411167. Epub 2024 Oct 10.
5
Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis.冠状动脉钙化在系统性硬化症中很常见,且与不良预后相关。
J Scleroderma Relat Disord. 2024 Oct;9(3):192-202. doi: 10.1177/23971983241264090. Epub 2024 Aug 11.
6
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis.2024 年英国风湿病学会系统性硬化症管理指南。
Rheumatology (Oxford). 2024 Nov 1;63(11):2956-2975. doi: 10.1093/rheumatology/keae394.
7
Systemic sclerosis: one year in review 2024.系统性硬皮病:2024 年回顾一年
Clin Exp Rheumatol. 2024 Aug;42(8):1517-1528. doi: 10.55563/clinexprheumatol/is29he. Epub 2024 Jul 26.
8
Portuguese Recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases.葡萄牙语推荐意见:系统性硬化症和其他结缔组织疾病的雷诺现象和指(趾)溃疡的管理。
ARP Rheumatol. 2024 Apr-Jun;3(2):84-94.
9
Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation.类风湿关节炎患者的动态血压:与免疫激活的关联。
J Rheumatol. 2024 Sep 1;51(9):870-876. doi: 10.3899/jrheum.2024-0205.
10
Association of Variability and Hypertensive Loads in 24-h Blood Pressure With Mortality and Cardiovascular Risk.24小时血压变异性及高血压负荷与死亡率和心血管风险的关联
Am J Hypertens. 2024 Apr 15;37(5):323-333. doi: 10.1093/ajh/hpae011.